IMPROVED METHOD FOR THE MEASUREMENT OF CIMETIDINE IN HUMAN SERUM BY REVERSE-PHASE HIGH-PRESSURE LIQUID CHROMATOGRAPHYLORENZO B; DRAYER DE.1981; J. LAB. CLIN. MED.; ISSN 0022-2143; USA; DA. 1981; VOL. 97; NO 4; PP. 545-550; BIBL. 14 REF.Article

CLINICAL CONSEQUENCES OF POLYMORPHIC ACETYLATION OF BASIC DRUGS.DRAYER DE; REIDENBERG MM.1977; CLIN. PHARMACOL. THERAPEUT.; U.S.A.; DA. 1977; VOL. 22; NO 3; PP. 251-258; BIBL. 2 P. 1/2Article

Bestimmung der Bodenerosionsgefährdung unter Verwendung amtlicher GIS-Daten = La détermination du risque d'érosion des sols grâce à l'utilisation des données officielles du SIGDRÄYER, D.Petermanns geographische Mitteilungen. 1995, Vol 139, Num 4, pp 201-214, issn 0031-6229Article

LIQUID CHROMATOGRAPHY AND FLUORESCENCE SPECTROSCOPY COMPARED WITH HOMOGENEOUS ENZYME IMMUNOASSAY TECHNIQUE FOR DETERMINING QUINIDINE IN SERUMDRAYER DE; LORENZO B; REIDENBERG MM et al.1981; CLIN. CHEM.; ISSN 0009-9147; USA; DA. 1981; VOL. 27; NO 2; PP. 308-310; BIBL. 9 REF.Article

SPECIFIC DETERMINATION OF QUINIDINE AND (3S)-3-HYDROXY-QUINIDINE IN HUMAN SERUM BY HIGH-PRESSURE LIQUID CHROMATOGRAPHY.DRAYER DE; RESTIVO K; REIDENBERG MM et al.1977; J. LAB. CLIN. MED.; U.S.A.; DA. 1977; VOL. 90; NO 5; PP. 816-822; BIBL. 12 REF.Article

N-ACETYLPROCAINAMIDE: AN ACTIVE METABOLITE OF PROCAINAMIDEDRAYER DE; REIDENBERG MM; SEVY RW et al.1974; PROC. SOC. EXPER. BIOL. MED.; U.S.A.; DA. 1974; VOL. 146; NO 2; PP. 358-363; BIBL. 23REF.Article

Basic clinical pharmacology of the antiarrhythmic drugs procainamide and quinidineDRAYER, D.Cardiovascular reviews & reports. 1990, Vol 11, Num 7, pp 44-52, issn 0197-3118Article

Arthritis of the subtalar joint associated with sustentaculum tali facet configurationDRAYER-VERHAGEN, F.Journal of anatomy (Print). 1993, Vol 183, pp 631-634, issn 0021-8782, 3Article

Problems in therapeutic drug monitoring: the dilemma of enantiomeric drugs in manDRAYER, D. E.Therapeutic drug monitoring. 1988, Vol 10, Num 1, pp 1-7, issn 0163-4356Conference Paper

Peggy J. Fritzsche, MD, President Radiological Society of North America, 2003DRAYER, Burton P.Radiology. 2003, Vol 226, Num 1, pp 10-11, issn 0033-8419, 2 p.Article

On the use of drugs administered as racematesDRAYER, D. E.Clinical pharmacology and therapeutics. 1987, Vol 42, Num 4, issn 0009-9236, 364Article

THE SIGNIFICANCE OF APOCALYPTICISM IN CONTEMPORARY BRITISH ESCHATOLOGYDRAYER J. K.DISSERT. ABSTR. INTERNAT., A. 1971, Vol 31, Num 8, PP. 4252Article

RENAL INJURY IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH GOLDMERLE LJ; REIDENBERG MM; CAMACHO MT et al.1980; CLIN. PHARMACOL. THER.; ISSN 0009-9236; USA; DA. 1980; VOL. 28; NO 2; PP. 216-222; BIBL. 33 REF.Article

ALTERATIONS IN STATE IN APNEIC PRE-TERM INFANTS RECEIVING THEOPHYLLINEDIETRICH J; KRAUSS AN; REIDENBERG M et al.1978; CLIN. PHARMACOL. THERAPEUT.; USA; DA. 1978; VOL. 24; NO 4; PP. 474-478; BIBL. 21 REF.Article

POLYMORPHIC ACETYLATION OF PROCAINAMIDE IN MAN = POLYMORPHISME DE L'ACETYLATION DU PROCAINAMIDE CHEZ L'HOMMEREIDENBERG MM; DRAYER DE; LEVY M et al.1975; CLIN. PHARMACOL. THERAPEUT.; U.S.A.; DA. 1975; VOL. 17; NO 6; PP. 722-730; BIBL. 1P.Article

AGE AND RENAL CLEARANCE OF CIMETIDINEDRAYER DE; ROMANKIEWICZ J; LORENZO B et al.1982; CLIN. PHARMACOL. THER.; ISSN 0009-9236; USA; DA. 1982; VOL. 31; NO 1; PP. 45-50; BIBL. 29 REF.Article

ANTIARRHYTHMIC ACTIVITY OF P-HYDROXY-N-(2-DIETHYLAMINOETHYL) BENZAMIDE (THE P-HYDROXY ISOSTERE OF PROCAINAMIDE) IN DOGS AND MICE.DRAYER DE; SLAVEN BH; REIDENBERG MM et al.1977; J. MEDICIN. CHEM.; U.S.A.; DA. 1977; VOL. 20; NO 2; PP. 270-274; BIBL. 29 REF.Article

IN VITRO ACETYLATION OF DRUGS BY HUMAN BLOOD CELLSDRAYER DE; STRONG JM; JONES B et al.1974; DRUG METABOL. DISPOSIT.; U.S.A.; DA. 1974; VOL. 2; NO 6; PP. 499-505; BIBL. 37REF.Article

ACETYLPROCAINAMIDE THERAPY IN PATIENTS WITH PREVIOUS PROCAINAMIDE-INDUCED LUPUS SYNDROMEKLUGER J; DRAYER DE; REIDENBERG MM et al.1981; ANN. INTERN. MED.; ISSN 0003-4819; USA; DA. 1981; VOL. 95; NO 1; PP. 18-23; BIBL. 19 REF.Article

AGING AND RENAL CLEARANCE OF PROCAINAMIDE AND ACETYLPROCAINAMIDEREIDENBERG M; CAMACHO M; KLUGER J et al.1980; CLIN. PHARMACOL. THER.; ISSN 0009-9236; USA; DA. 1980; VOL. 28; NO 6; PP. 732-735; BIBL. 14 REF.Article

ANTIBODIES TO NUCLEAR ANTIGENS IN PATIENTS TREATED WITH PROCAINAMIDE OR ACETYLPROCAINAMIDELAHITA R; KLUGER J; DRAYER DE et al.1979; NEW ENGLAND J. MED.; USA; DA. 1979; VOL. 301; NO 25; PP. 1382-1385; BIBL. 28 REF.Article

N-ACETYL-BETA -GLUCOSAMINIDASE AND BETA _D2-MICROGLOBULIN. THEIR URINARY EXCRETION IN PATIENTS WITH RENAL PARENCHYMAL DISEASESHERMAN RL; DRAYER DE; LEYLAND JONES BR et al.1983; ARCHIVES OF INTERNAL MEDICINE (1960); ISSN 0003-9926; USA; DA. 1983; VOL. 143; NO 6; PP. 1183-1185; BIBL. 15 REF.Article

MICROSOMAL HYDROXYLATION AS MEASURED BY PENTOBARBITAL ELIMINATION IN PATIENTS WITH IDIOPATHIC SYSTEMIC LUPUS ERYTHEMATOSUSDRAYER DE; LORENZO B; LAHITA RG et al.1982; CLINICAL PHARMACOLOGY AND THERAPEUTICS; ISSN 0009-9236; USA; DA. 1982; VOL. 32; NO 2; PP. 195-200; BIBL. 33 REF.Article

UNUSUAL CAUSE OF THEOPHYLLINE TOXICITYGOTZ VP; DRAYER DE; SCHNED ES et al.1979; NEW YORK STATE J. MED.; USA; DA. 1979; VOL. 79; NO 8; PP. 1232-1234; BIBL. 17 REF.Article

HEIGHT OF DIABETIC CHILDREN AT ONSET OF SYMPTOMS = LA TAILLE DES ENFANTS DIABETIQUES AU DEBUT DES SYMPTOMESDRAYER NM.1974; ARCH. DIS. CHILDH.; G.B.; DA. 1974; VOL. 49; NO 8; PP. 616-620; BIBL. 24REF.Article